Cargando…
Anticoagulation Strategies and Determining the Rate of Fatal Intracerebral Hemorrhage Associated With Venovenous Extracorporeal Membrane Oxygenation in Patients With Coronavirus Disease 2019
Autores principales: | Kelly, Adam, Head, Laura, Garcia, Miguel, Hayes, Tim, Charlesworth, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584492/ https://www.ncbi.nlm.nih.gov/pubmed/33189536 http://dx.doi.org/10.1053/j.jvca.2020.10.039 |
Ejemplares similares
-
Anticoagulation in COVID-19-positive Patients on Venovenous Extracorporeal Membrane Oxygenation
por: Patel, Mayuri, et al.
Publicado: (2022) -
Awake Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 Acute Respiratory Failure
por: Assanangkornchai, Nawaporn, et al.
Publicado: (2021) -
Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19
por: Seelhammer, Troy G., et al.
Publicado: (2021) -
Tracheobronchial Stent Insertion Under Venovenous Extracorporeal Membrane Oxygenation in a Patient With Coronavirus Disease 2019
por: Ichinomiya, Taiga, et al.
Publicado: (2022) -
Six-Month Pulmonary Function After Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 Patients
por: Ego, Amédée, et al.
Publicado: (2021)